PD-1 ANTIBODY

Clinical trials for PD-1 ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new PD-1 ANTIBODY trials appear

Sign up with your email to follow new studies for PD-1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New combo therapy aims to control advanced lung cancer

Disease control Recruiting now

This study tests whether combining two types of drugs (EGFR-TKIs and a PD-1 antibody) can help control advanced non-small cell lung cancer with specific EGFR mutations. It involves 32 adults who have not had prior treatment. The main goal is to see how long the cancer stays under…

Matched conditions: PD-1 ANTIBODY

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Jun 18, 2026 11:49 UTC

PD-1 ANTIBODY

Get alerted when new PD-1 ANTIBODY trials appear

New combo therapy aims to control advanced lung cancer